Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contrast-enhanced ultrasound-facilitated thrombolysis for acute peripheral arterial occlusion
2014-003469-10Phase 2Active
- Sponsor
- VU University Medical Center
- Start
- Jul 2015
- Modality
- Drug Delivery Systems, Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of perflutren lipid microspheres and urokinase in Acute limb ischaemia (ALI) and peripheral artery occlusion (PAD), sponsored by VU University Medical Center. Primary endpoints: Duration of thrombolysis to restore uninterrupted flow, Lower limb microcirculation and 2 more. Started Jul 2015; status: active.
02
Drugs
perflutren lipid microspheresurokinase
03
Conditions
Acute limb ischaemia (ALI)peripheral artery occlusion (PAD)
Beyond the preview
Go deeper on 2014-003469-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003469-10.